Hogar...with respect "I am not sure what your issue is with the BO word?"
The threads here do and should deal with the many possibilities that are out there for Ariad including science, business, investment, management, history and more. Certainly ONE of those is a BO by a larger company for a myriad of reasons.
To me, Dr. Denner is on board (as Chairman of the BOD, head of Sarissa, activist investor and known player in the Biotech Investment Community) for the following reason only:
To: "Reorganize, regroup, revalue, reevaluate (not necessarily in that order) the company in all areas to create an attractive BO target and maximize shareholder value (and yes he is a major shareholder)".
Whether we like it or not, BO is part of his DNA...or RNA for the science people here. Bad joke!!!
IMHO, this could happen from now until the situation is "right" which means Ariad is positioned optimally and/or the buyer wants it to happen at the right price (the right price being simply what Denner thinks is right).
I for one embrace the endless possibilities and creative approach that the new regime has or is implementing from a position of strength and with patience and a strategy (albeit many factors and moves unknown to us). IMHO
AI
